Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma

Details for Australian Patent Application No. 2007260145 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Inventors Roberto, Camerini; Carminati, Paolo

Agent Lord and Company

Pub. Number AU-A-2007260145

PCT Pub. Number WO2007/144218

Priority 11/734,592 12.04.07 US; 11/424,475 15.06.06 US

Filing date 17 April 2007

Wipo publication date 21 December 2007

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/144218 Priority application(s): WO2007/144218

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260158-Machine with uncooled rotor body and cooled rotor winding and associated holding and/or support device

2007260139-Apparatus and process for continuously preparing ethylene cyanohydrin